Research News

Could a drug that controls appetite also treat schizophrenia and Alzheimer’s? Mouse studies show promise.
September 8, 2021 - Two recent studies suggest that the drug trodusquemine has the potential to treat symptoms of both schizophrenia and Alzheimer’s disease. This is because the drug targets an enzyme called PTP1B, which plays a role in both diseases
A conversation with Dr. Jess Fiedorowicz
August 18, 2021 - Dr. Jess Fiedorowicz is shining a light on mental health through his work and research at The Ottawa Hospital. Originally from the U.S., Dr. Fiedorowicz has been at our hospital since 2020 as the Head and Chief of the Department of Mental Health.
Study in mice reveals possible new target to treat schizophrenia
March 10, 2021 - The enzyme PTP1B may be a new target for treating schizophrenia, according to a study published in Neuropsychopharmacology.
Show more news stories